Vasomune doses first subjects in Covid-19 treatment trial,

Clinical-stage biopharma firm Vasomune Therapeutics has dosed the first subjects in a Phase I study of its potential vascular normalisation Covid-19 …, Clinical-stage biopharma firm Vasomune Therapeutics has dosed the first subjects in a Phase I study of its potential vascular normalisation Covid-19 …, Read More

Scroll to Top